About Emulate
Emulate is a company based in Boston (United States) founded in 2013 by Daniel Levner. Emulate has raised $204.49 million across 9 funding rounds from investors including LabCorp, Cedars Sinai and HHS. Emulate offers products and services including Organ-Chip, Software Platform, Consumables, and BioKits. Emulate operates in a competitive market with competitors including CN Bio, AxoSim, Mimetas, Nortis and NETRI, among others.
- Headquarter Boston, United States
- Founders Daniel Levner
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website emulatebio.com
- Social LinkedIn X Instagram YouTube
- Total Equity Funding$204.49M (USD)
in 9 rounds
- Latest Funding Round$82M (USD), Series E
Sep 2021
- InvestorsLabCorp
& 14 more
Products & Services of Emulate
Emulate offers a comprehensive portfolio of products and services, including Organ-Chip, Software Platform, Consumables, and BioKits.
Microfluidic tool for simulating human organ functions in research
Platform for managing and analyzing Organ-Chip experiment data
Materials supporting Organ-Chip operations in laboratory settings
Kits for specific applications like disease modeling
Apps and channels of Emulate
its YouTube channel Emulate, Inc. has 801 subscribers and 24 videos.
Videos from Emulate
The most watched videos on Emulate's YouTube channel, Emulate, Inc. (801 subscribers). Click a video to play it here.
More on Emulate, Inc..
Funding Insights of Emulate
Emulate has successfully raised a total of $204.49M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $82 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $204.49M
- Total Rounds 9
- Last Round Series E — $82M
- First Round $12M
(Jul 2014)
- Investors Count 15
All 9 funding rounds of Emulate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | $82M | Series E | – | Perceptive Advisors, Northpond Ventures | – |
| Mar 2020 | $19.27M | Debt – Conventional | – | – | – |
| Aug 2019 | $27.99M | Series C | – | – | – |
| Jun 2018 | $36M | Series C | – | Founders Fund | |
| Mar 2018 | $149,996 | Grant | – | – | |
| Oct 2017 | $745,750 | Series B | – | – | – |
| Oct 2016 | $17M | Series B | – | Sinai, OS Fund | |
| Mar 2016 | $28.75M | Series B | – | OS Fund, ATEL Capital Group | |
| Jul 2014 | $12M | Series A | – | Sinai, ND Capital |
15 investors in total: 14 institutional and 1 angel.
Investors in Emulate
Emulate has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LabCorp, Cedars Sinai and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Venture capital firm investing in life sciences & tech sectors | – | npv.vc | Cambridge, United States | |
Venture capital investments in technology and defense sectors. | – | foundersfund.com | - | |
A venture capital fund focused on biotech for neurodegeneration. | – | alsinvestmentfund.com | Amsterdam, Netherlands | |
Investments are directed toward early-stage consumer-tech startups. | – | scifi.vc | San Francisco, United States | |
Venture capital firm investing in impact sectors | – | glasswallsyndicate.org | Leawood, United States | |
Early-stage centric sector-agnostic VC firm investing in geographies such as the US | – | osfund.co | Chicago, United States | |
Tech startups are invested in by this venture capital firm. | – | nd.capital | Woodside, United States | |
VC & private debt firm focused on tech companies | 1977 | atel.com | San Francisco, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Emulate
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Emulate
40 people are tracked at Emulate (11 in leadership, 6 in board & advisors, 23 in team).
| Name | Role | Group |
|---|---|---|
Daniel Levner | Co-Founder & CTO | Leadership |
Lauren Feldman | Executive Assistant To Chief Executive Officer | Leadership |
Jim Corbett | CEO & Board Member | Leadership |
Lorna Ewart | Chief Scientific officer | Leadership |
Josiah Sliz | VP, Platform Development | Leadership |
Jefferson Puerta | Senior Director, Systems Engineering | Leadership |
Stacy Schorr | VP, People | Leadership |
Benjamin Paradis | Associate Director Of Product Management, Software & Cloud Applications | Leadership |
Anthony Pisello | Director Of IT Systems | Leadership |
Kirsty Zhe Lyu | General Manager APAC | Leadership |
Randy Daughters | Director Of Neuroscience And Head Of Discovery Biology MPS | Leadership |
Franklin R. Witney | Board Member | Board & advisors |
Martin Madaus | Executive Chairman | Board & advisors |
Shlomo Melmed | Board Member | Board & advisors |
Eric Moessinger | Board Member | Board & advisors |
Jose-Carlos Gutiérrez-Ramos | Board Member | Board & advisors |
Sharon Kedar | Board Member | Board & advisors |
Taehee L. | Product Development Engineer III | Team |
Max Winkelman | Scientist III | Team |
Lester Chong | Product Development Engineer III | Team |
20 more people are available in the full profile.
Complete people profiles for Emulate
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Emulate
3 dated milestones of Emulate across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Emulate is founded.
- Funding First funding round of $12.0M.
- Funding Latest funding round, Series E, of $82.0M.
Competitors of Emulate
Emulate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CN Bio, AxoSim, Mimetas, Nortis and NETRI, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| cellboxlabs.com | 2020 | Riga, Latvia | $1.01M | 10 | Organ-on-chip platform is provided for drug discovery and development. | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. |
Detailed competitors of Emulate
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Emulate
The website of Emulate (emulatebio.com) receives about 35.5K visits a month.
- Monthly visits35.5K
▼ 4.4% vs previous month
Websites whose visitors overlap most with Emulate. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mimetas.com | 100% | 17.2K | #1,469,072 | View details | |
| curibio.com | 96% | 7K | #3,017,939 | View details | |
creative-biolabs.com | creative-biolabs.com | 95% | – | #348,062 | – |
| promocell.com | 85% | – | #944,821 | View details | |
ijbs.com | ijbs.com | 85% | – | #341,874 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Emulate
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Emulate
Complete news archive for Emulate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Emulate
10 companies that operate in the same segment as Emulate (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emulate
Emulate was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Emulate is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Emulate is a funded company, having raised a total of $204.49M across 9 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Jul 2014.
The company was founded in 2013 in Boston, United States, and operates in the biotechnology sector focused on drug development. In vitro models, including organ-chips for the liver, intestine, kidney, and other organs, are developed to simulate human physiology. These models feature tiny channels lined with living human cells and tissues for predicting responses. Culture modules and analytical software applications are also provided to support research operations.
Emulate's top competitors include CN Bio, Cellbox Labs and Nortis.
Emulate offers Organ-Chip, Software Platform, Consumables, and BioKits.
Emulate has 15 investors. Key investors include LabCorp, Cedars Sinai, HHS, Perceptive Advisors, and ATEL Capital Group.